Zaleplon increases nocturnal melatonin secretion in humans

被引:7
作者
Morera, A. L. [1 ]
Abreu-Gonzalez, P. [2 ]
Henry, M. [1 ]
机构
[1] Univ La Laguna, Sch Med, Dept Internal Med Dermatol & Psychiat, Santa Cruz de Tenerife, Canary Islands, Spain
[2] Univ La Laguna, Sch Med, Dept Physiol, Santa Cruz de Tenerife, Canary Islands, Spain
关键词
Circadian rhythms; Hypnotics; Insomnia; Melatonin; Sleep; Zaleplon; RAT PINEAL-GLAND; PLASMA MELATONIN; HORMONAL PROFILES; SLEEP; ZOPICLONE; ZOLPIDEM; NEUROTRANSMITTERS; BENZODIAZEPINES; SUPPRESSION; ALPRAZOLAM;
D O I
10.1016/j.pnpbp.2009.05.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Insomnia is the most common steep condition. Many hypnotics decrease nocturnal melatonin secretion. The aim of this research consists of studying the effect of the hypnotic drug zaleplon on melatonin secretion. Twelve non-smoker drug-free healthy male subjects participated in the study. All participants were normal sleepers and aged 33.2 +/- 11.7 years. They orally took 10 mg of zaleplon at 22:00 h in a double-blind, randomized, cross-over design. The study was carried out during two consecutive days in a week-end. Blood samples were extracted at 22:00, 23:00, 24:00, 01:00, 02:00 and 12:00 h. Melatonin was measured by an ELISA assay. All the subjects had a circadian rhythm of melatonin secretion. Zaleplon compared to placebo increased significantly the melatonin levels at 23:00, 24:00 and 01:00 h. No differences in melatonin levels between placebo and zaleplon were found at 12:00, 22:00 and 02:00 h. Zaleplon compared to placebo increased by 46% the Area Under the Curve of melatonin secretion. The present study indicates that zaleplon increases nocturnal melatonin secretion without increasing daytime melatonin levels. We suggest that when clinicians prescribe a hypnotic, the effect on melatonin levels should be another parameter to be taken into account. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1013 / 1016
页数:4
相关论文
共 36 条
[1]   THE EFFECT OF TEMAZEPAM ON MELATONIN SECRETION AND LIGHT SENSITIVITY [J].
ALLEN, NHP ;
SMYTHE, PJ ;
MARTIN, N ;
PLASKETT, E ;
OSOLA, K ;
CHILDS, P ;
THOMPSON, C .
JOURNAL OF PSYCHOPHARMACOLOGY, 1994, 8 (02) :94-97
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3]   ABC OF SLEEP DISORDERS - I DONT GET ENOUGH SLEEP, DOCTOR [J].
BERRIOS, GE ;
SHAPIRO, CM .
BRITISH MEDICAL JOURNAL, 1993, 306 (6881) :843-846
[4]  
Blais FC, 2001, CAN FAM PHYSICIAN, V47, P759
[5]   URINARY MELATONIN, LH, ESTRADIOL, PROGESTERONE EXCRETION DURING THE MENSTRUAL-CYCLE OR IN WOMEN TAKING ORAL-CONTRACEPTIVES [J].
BRUN, J ;
CLAUSTRAT, B ;
DAVID, M .
ACTA ENDOCRINOLOGICA, 1987, 116 (01) :145-149
[6]   EFFECTS OF BEDTIME ADMINISTRATION OF ZOLPIDEM ON CIRCADIAN AND SLEEP-RELATED HORMONAL PROFILES IN NORMAL WOMEN [J].
COPINSCHI, G ;
AKSEKI, E ;
MORENOREYES, R ;
LEPROULT, R ;
LHERMITEBALERIAUX, M ;
CAUFRIEZ, A ;
VERTONGEN, F ;
VANCAUTER, E .
SLEEP, 1995, 18 (06) :417-424
[7]  
COPINSCHI G, 1990, SLEEP, V13, P232
[8]  
Dämgen K, 1999, NEUROSCI RES COMMUN, V25, P139, DOI 10.1002/(SICI)1520-6769(199911/12)25:3<139::AID-NRC3>3.0.CO
[9]  
2-W
[10]   POSTURE INFLUENCES MELATONIN CONCENTRATIONS IN PLASMA AND SALIVA IN HUMANS [J].
DEACON, S ;
ARENDT, J .
NEUROSCIENCE LETTERS, 1994, 167 (1-2) :191-194